Fig 5. ROC analysis of anti-CD300e antibody.
A: ROC analysis of patients with FT1D in the acute phase (n = 26) and HC (n = 30). B: ROC analysis of patients with FT1D in the acute phase (n = 26) and T1AD (n = 32).
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.